Potassium-chloride cotransporter (KCC)

The potassium-chloride cotransporters (KCCs) are a family of membrane transport proteins responsible for the electroneutral, secondary active symport of potassium (K⁺) and chloride (Cl⁻) ions across the plasma membrane, driven by the K⁺ gradient established by Na⁺/K⁺-ATPase[3][6]. Four main isoforms exist in humans (KCC1/KCC2/KCC3/KCC4, genes SLC12A4/5/6/7), each with distinctive tissue expression and physiological roles: KCC1 is ubiquitous and maintains cell volume in various tissues; KCC2 is neuron-specific and essential for inhibitory synaptic signaling; KCC3 and KCC4 play key roles in cell proliferation, sensory function, kidney function, and are implicated in disease pathogenesis such as hypertension, epilepsy, neuropathies, deafness, and hemoglobinopathies[3][4][5][6][7][8]. KCCs are promising drug targets but present significant challenges due to isoform diversity and widespread expression.

Other names

Potassium chloride cotransporterKCl cotransporterCation-chloride cotransporterSLC12 family (KCC1, KCC2, KCC3, KCC4)SLC12A4 (KCC1)SLC12A5 (KCC2)SLC12A6 (KCC3)SLC12A7 (KCC4)

Inhibition or activation alters chloride and potassium homeostasis, modulating cell volume and neuronal inhibition[6] Enhancers (agonists) of KCC2 increase chloride extrusion from neurons, supporting inhibition Inhibitors of KCC1 prevent red blood cell dehydration (useful in sickle cell disease)[8]